Katie Lewis

534 total citations
38 papers, 170 citations indexed

About

Katie Lewis is a scholar working on Pulmonary and Respiratory Medicine, Genetics and Oncology. According to data from OpenAlex, Katie Lewis has authored 38 papers receiving a total of 170 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pulmonary and Respiratory Medicine, 16 papers in Genetics and 15 papers in Oncology. Recurrent topics in Katie Lewis's work include Advanced Breast Cancer Therapies (18 papers), BRCA gene mutations in cancer (16 papers) and PARP inhibition in cancer therapy (6 papers). Katie Lewis is often cited by papers focused on Advanced Breast Cancer Therapies (18 papers), BRCA gene mutations in cancer (16 papers) and PARP inhibition in cancer therapy (6 papers). Katie Lewis collaborates with scholars based in United Kingdom, United States and Germany. Katie Lewis's co-authors include Laura Paulette, Бин Ли, Somsubhra Chakraborty, David C. Weindorf, A. Rider, Michael P. Lux, Bhakti Arondekar, Reshma Mahtani, François Ringeisen and Xavier Pivot and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Annals of Oncology.

In The Last Decade

Katie Lewis

31 papers receiving 167 citations

Peers

Countries citing papers authored by Katie Lewis

Since Specialization

Citations

This map shows the geographic impact of Katie Lewis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katie Lewis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katie Lewis more than expected).

Fields of papers citing papers by Katie Lewis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katie Lewis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katie Lewis. The network helps show where Katie Lewis may publish in the future.

Co-authorship network of co-authors of Katie Lewis

This figure shows the co-authorship network connecting the top 25 collaborators of Katie Lewis. A scholar is included among the top collaborators of Katie Lewis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katie Lewis. Katie Lewis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Real-World Study of the Burden of Myelodysplastic Syndromes in Patients and Their Caregivers in Europe and the United States 2024 ·Oncology and Therapy ·Katie Lewis, (unknown), (unknown), (unknown), Cosmina Hogea	1
2	Soil bacterial and fungal microbiomes under cotton production are more sensitive to tillage and cover crops than irrigation level in a semi-arid sandy soil 2024 ·Applied Soil Ecology ·(unknown), Verónica Acosta‐Martínez, (unknown), Katie Lewis, Joshua J. Steffan, Lindsey C. Slaughter	0
3	Real-world clinical profile, RET mutation testing, treatments and patient-related outcomes for medullary thyroid cancer in Europe 2024 ·European Thyroid Journal ·(unknown), Ravinder Singh, Min‐Hua Jen, (unknown), A. Rider, Katie Lewis, Urpo Kiiskinen	1
4	463P A real-world study to evaluate biomarker testing and treatment management in patients with locally advanced unresectable or metastatic G/GEJ adenocarcinoma in France, Germany, Italy, Spain, UK and Canada: Adelphi Real World G/GEJ cancer disease specific programme 2024 ·Annals of Oncology ·(unknown), (unknown), Katie Lewis, (unknown), (unknown), Eleanor Brown, (unknown), (unknown), C. Streutker, F. Rivera Herrero, (unknown)	0
5	Soil Potassium Effects on Cotton Lint Yield and Fiber Quality on the Texas High Plains 2023 ·The journal of cotton science/Journal of cotton science ·(unknown), Katie Lewis, Seth A. Byrd, Glen L. Ritchie, Gaylon D. Morgan	1
6	Real-World Clinical Profile, Treatment Patterns And Patient-Reported Outcomes for Thyroid Cancer in Japan 2023 ·Future Oncology ·Naoki Fukuda, Yoshinori Tanizawa, (unknown), (unknown), (unknown), Urpo Kiiskinen, Nicolas Fasnacht, (unknown), A. Rider, Katie Lewis	0
7	Real-World Multi-Country Study of BRCA1/2 Mutation Testing Among Adult Women with HER2-Negative Advanced Breast Cancer 2022 ·Future Oncology ·Michael P. Lux, Katie Lewis, A. Rider, (unknown)	2
8	Treatment Patterns, Safety, and Patient Reported Outcomes among Adult Women with Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer with or without, or with Unknown, BRCA1/2 Mutation(s): Results of a Real-World Study from the United States, United Kingdom, and four EU Countries 2022 ·Breast Care ·Michael P. Lux, Katie Lewis, A. Rider, (unknown)	3
9	Real-world patient-reported outcomes and physician satisfaction with poly (ADP-ribose) polymerase inhibitors versus chemotherapy in patients with germline BRCA1/2-mutated human epidermal growth factor receptor 2–negative advanced breast cancer from the United States, Europe, and Israel 2022 ·BMC Cancer ·Reshma Mahtani, (unknown), Bhakti Arondekar, Katie Lewis, A. Rider, (unknown), Michael P. Lux	1
10	Real-world study of patients with germline BRCA1/2-mutated human epidermal growth factor receptor 2‒Negative advanced breast cancer: Patient demographics, treatment patterns, adverse events, and physician-reported satisfaction in the United States, Europe, and Israel 2022 ·The Breast ·Reshma Mahtani, (unknown), Bhakti Arondekar, Katie Lewis, A. Rider, (unknown), Michael P. Lux	4
11	Real-World Study of Regional Differences in Patient Demographics, Clinical Characteristics, and BRCA1/2 Mutation Testing in Patients with Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer in the United States, Europe, and Israel 2022 ·Advances in Therapy ·Reshma Mahtani, (unknown), Katie Lewis, A. Rider, (unknown), Bhakti Arondekar, Michael P. Lux	7
12	Initiation of bone-targeted agents in patients with bone metastases and breast or castrate-resistant prostate cancer actively treated in routine clinical practice in Europe 2021 ·Bone ·Roger von Moos, Katie Lewis, (unknown), Andrea Marongiu, A. Rider, (unknown)	8
13	Real-world clinical profile, treatment patterns and patient-reported outcomes in a subset of HR+/HER2- advanced breast cancer patients with poor prognostic factors: data from an international study 2021 ·ESMO Open ·(unknown), (unknown), A. Rider, (unknown), Katie Lewis, (unknown), (unknown), François Ringeisen, Xavier Pivot	5
14	312P Real-world (RW) multi-country study of BRCA1/2 mutation (BRCA1/2mut) testing trends among adult patients (pts) with HER2− advanced breast cancer (ABC) 2020 ·Annals of Oncology ·Reshma Mahtani, (unknown), Katie Lewis, (unknown), A. Rider, Bhakti Arondekar, Michael P. Lux	1
15	314P Real-world (RW) multi-country study of BRCA1/2 testing in adult patients (pts) with HER2−advanced breast cancer (ABC) 2020 ·Annals of Oncology ·Michael P. Lux, (unknown), Katie Lewis, A. Rider, Bhakti Arondekar, Reshma Mahtani	1
16	327P Treatment sequencing in HR+/HER2- locally advanced or metastatic breast cancer: A real-world retrospective study in France, Germany, Italy and Spain 2020 ·Annals of Oncology ·Katie Lewis, Samantha K. Kurosky, (unknown), Debanjali Mitra, (unknown), Reshma Mahtani	1
17	157P Germline BRCA1/2 (gBRCA1/2) testing patterns among oncologists (ONC) treating HER2- advanced breast cancer (ABC): Results from a multi-country real-world study 2020 ·Annals of Oncology ·Reshma Mahtani, (unknown), Katie Lewis, (unknown), A. Rider, Bhakti Arondekar, Michael P. Lux	1
18	BRCA status, treatment patterns and outcomes in HER2- advanced breast cancer (ABC): A multi-country real-world study 2019 ·Annals of Oncology ·(unknown), (unknown), Katie Lewis, (unknown), A. Rider	1
19	PCN489 REAL WORLD MULTI-COUNTRY RETROSPECTIVE STUDY OF TREATMENT TRAVEL TIME AND WORK PRODUCTIVITY BURDEN AMONG HER2- NEGATIVE ADVANCED BREAST CANCER PATIENTS WITH A BRCA1/2 MUTATION 2019 ·Value in Health ·(unknown), Katie Lewis, A. Rider	1
20	Investigator-assessed efficacy and safety of sonidegib in patients with locally advanced basal cell carcinoma and metastatic basal cell carcinoma: results of the BOLT 30-month analysis 2016 ·Melanoma Research ·John T. Lear, (unknown), Ralf Gutzmer, Michael R. Migden, Ragini R. Kudchadkar, Katie Lewis, L. Dirix, Ruth Plummer, Alexander Stratigos, Anne Lynn S. Chang, Uwe Trefzer, Carmen Loquai, Martin Kaatz, P. Combemale, Manisha Mone, Henry Castro, Tingting Yi, Dalila Sellami, Reinhard Dummer	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact